MiH will assist to develop your value proposition: a strategy to maximise the value of your products given the available evidence and the essential gaps in this evidence.
MiH will maximise the benefits of available evidence through tailored scientific methods.
MiH will fill essential gaps by conducting projects that generate new evidence.
MiH will provide training and assist you with the communication and dissemination of your findings.
we are dedicated to
OF YOUR PRODUCT
-
Utilities studies (TTO, DCE and more)MiH can obtain utilities for QALY calculations directly from patients’ preferences when they value specific health states (E.g. using vignettes)
-
Risk/benefits analysisMiH can demonstrate value through patient and other stakeholder preferences (for treatment benefits and risk of side effects; convenience/mode of administration/duration of treatment; cost)
-
Actionable evidence from expertsMiH can gather critical insights from experts through online structured interviews and Delphi panels.
-
Prospective studies designMiH can assist with protocol development and statistical analyses (clinical trials, clinical outcome assessment/patient-reported outcomes measures, resource utilisation and costs)
MiH can review all available evidence related to your product and demonstrate value through meta-analysis and indirect treatment comparison
MiH can conduct statistical analysis of existing datasets (RCT, COA, PROMs, HRQoL, resource utilisation, costs) to demonstrate value
Maximizing the benefits of available evidence
MiH can model disease and treatment pathways or enhance existing models to demonstrate value for money.
MiH can build models for pricing strategies, including risk-sharing agreements that demonstrate value.
